All data are based on the daily closing price as of September 6, 2024
g
Genomictree
228760.KQ
11.71 USD
-0.50
-4.10%
Overview
Last close
11.71 usd
Market cap
281.23M usd
52 week high
21.83 usd
52 week low
9.07 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
183.1314
Price/Book Value
2.9022
Enterprise Value
206.30M usd
EV/Revenue
135.3418
EV/EBITDA
24.3324
Key financials
Revenue TTM
1.52M usd
Gross Profit TTM
34423.3 usd
EBITDA TTM
-9.89M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
136.90B usd
Net debt
N/A usd
About
Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kit for vitro qualitative detection of RNA in nasopharyngeal or oropharyngeal swabs, test providers, and nucleic acid transport medium. Genomictree Inc. was founded in 2000 and is headquartered in Daejeon, South Korea.